These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 9731114)

  • 1. Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy.
    Segawa Y; Shirao Y; Yamagishi S; Higashide T; Kobayashi M; Katsuno K; Iyobe A; Harada H; Sato F; Miyata H; Asai H; Nishimura A; Takahira M; Souno T; Segawa Y; Maeda K; Shima K; Mizuno A; Yamamoto H; Kawasaki K
    Ophthalmic Res; 1998; 30(6):333-9. PubMed ID: 9731114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products increase retinal vascular endothelial growth factor expression.
    Lu M; Kuroki M; Amano S; Tolentino M; Keough K; Kim I; Bucala R; Adamis AP
    J Clin Invest; 1998 Mar; 101(6):1219-24. PubMed ID: 9502762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells.
    Hirata C; Nakano K; Nakamura N; Kitagawa Y; Shigeta H; Hasegawa G; Ogata M; Ikeda T; Sawa H; Nakamura K; Ienaga K; Obayashi H; Kondo M
    Biochem Biophys Res Commun; 1997 Jul; 236(3):712-5. PubMed ID: 9245719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195.
    Tsuchida K; Makita Z; Yamagishi S; Atsumi T; Miyoshi H; Obara S; Ishida M; Ishikawa S; Yasumura K; Koike T
    Diabetologia; 1999 May; 42(5):579-88. PubMed ID: 10333051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Otsuka Long-Evans Tokushima fatty (OLETF) rat is not a suitable animal model for the study of angiopathic diabetic retinopathy.
    Matsuura T; Yamagishi S; Kodama Y; Shibata R; Ueda S; Narama I
    Int J Tissue React; 2005; 27(2):59-62. PubMed ID: 16035649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats.
    Stitt AW; Bhaduri T; McMullen CB; Gardiner TA; Archer DB
    Mol Cell Biol Res Commun; 2000 Jun; 3(6):380-8. PubMed ID: 11032761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ANG II in coronary capillary angiogenesis at the insulin-resistant stage of a NIDDM rat model.
    Jesmin S; Hattori Y; Sakuma I; Mowa CN; Kitabatake A
    Am J Physiol Heart Circ Physiol; 2002 Oct; 283(4):H1387-97. PubMed ID: 12234789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of vascular endothelial growth factor expression by advanced glycation end products.
    Treins C; Giorgetti-Peraldi S; Murdaca J; Van Obberghen E
    J Biol Chem; 2001 Nov; 276(47):43836-41. PubMed ID: 11571295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.
    Poulaki V; Qin W; Joussen AM; Hurlbut P; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    J Clin Invest; 2002 Mar; 109(6):805-15. PubMed ID: 11901189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products increase, through a protein kinase C-dependent pathway, vascular endothelial growth factor expression in retinal endothelial cells. Inhibitory effect of gliclazide.
    Mamputu JC; Renier G
    J Diabetes Complications; 2002; 16(4):284-93. PubMed ID: 12126787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats.
    Obrosova IG; Minchenko AG; Marinescu V; Fathallah L; Kennedy A; Stockert CM; Frank RN; Stevens MJ
    Diabetologia; 2001 Sep; 44(9):1102-10. PubMed ID: 11596663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal changes in Otsuka long-evans Tokushima Fatty rats (spontaneously diabetic rat)--possibility of a new experimental model for diabetic retinopathy.
    Lu ZY; Bhutto IA; Amemiya T
    Jpn J Ophthalmol; 2003; 47(1):28-35. PubMed ID: 12586175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas.
    Murata T; Nagai R; Ishibashi T; Inomuta H; Ikeda K; Horiuchi S
    Diabetologia; 1997 Jul; 40(7):764-9. PubMed ID: 9243096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-induced vascular endothelial growth factor expression in retina.
    Lu M; Amano S; Miyamoto K; Garland R; Keough K; Qin W; Adamis AP
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3281-6. PubMed ID: 10586954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of diabetic retinopathy with angiopoietin-1.
    Joussen AM; Poulaki V; Tsujikawa A; Qin W; Qaum T; Xu Q; Moromizato Y; Bursell SE; Wiegand SJ; Rudge J; Ioffe E; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 May; 160(5):1683-93. PubMed ID: 12000720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
    Joussen AM; Poulaki V; Qin W; Kirchhof B; Mitsiades N; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 Feb; 160(2):501-9. PubMed ID: 11839570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species accelerate production of vascular endothelial growth factor by advanced glycation end products in RAW264.7 mouse macrophages.
    Urata Y; Yamaguchi M; Higashiyama Y; Ihara Y; Goto S; Kuwano M; Horiuchi S; Sumikawa K; Kondo T
    Free Radic Biol Med; 2002 Apr; 32(8):688-701. PubMed ID: 11937295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cell biology of intraocular vascular diseases].
    Ishibashi T
    Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes.
    Sugiyama T; Okuno T; Fukuhara M; Oku H; Ikeda T; Obayashi H; Ohta M; Fukui M; Hasegawa G; Nakamura N
    Exp Eye Res; 2007 Sep; 85(3):406-12. PubMed ID: 17678894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
    Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
    Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.